Literature DB >> 29453944

Clinical Features of Extrapulmonary Sarcoidosis Without Lung Involvement.

Walter Ennis James1, Efstratios Koutroumpakis2, Biplab Saha2, Alireza Nathani2, Leahruth Saavedra2, Recai M Yucel3, Marc A Judson2.   

Abstract

BACKGROUND: Compared with pulmonary sarcoidosis, sarcoidosis without lung involvement may involve other immunopathologic mechanisms and be associated with other demographic and clinical features.
METHODS: This was a retrospective analysis of clinical data collected in real time on 1,686 patients with biopsy-proven sarcoidosis from two large university sarcoidosis outpatient clinics in the United States. We compared differences in demographics characteristics and clinical presentation between pulmonary and nonpulmonary sarcoidosis (NPS). Patients were considered to have NPS only if they had normal chest imaging and no features consistent with pulmonary involvement on the basis of currently accepted criteria.
RESULTS: A total of 8.3% of this sarcoidosis cohort met criteria for NPS. NPS was significantly more common in white than black patients, and more common in women than men. The skin was the most common organ involved, and was observed in nearly one-half of patients with NPS. Isolated skin sarcoidosis was the overwhelmingly most common pattern of organ involvement seen in the NPS group (25%), and no other pattern of involvement was found in more than 5% of patients with NPS.
CONCLUSIONS: Significant demographic and sex differences were observed between patients with pulmonary and nonpulmonary sarcoidosis. These differences reflect previous data concerning differences between patients with skin and lung sarcoidosis because the skin was the major organ involved with NPS. Although the lungs are likely the primary site of exposure in pulmonary sarcoidosis, the high prevalence of skin involvement in NPS suggests the skin is the most conducive site of antigen capture outside of the respiratory tract.
Copyright © 2018 American College of Chest Physicians. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  chest imaging; interstitial lung disease; sarcoidosis

Mesh:

Year:  2018        PMID: 29453944     DOI: 10.1016/j.chest.2018.02.003

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  16 in total

1.  An unusual cause of ascites and pleural effusion in an elderly woman: Sarcoidosis presenting with parailiac lymph node involvement.

Authors:  Abdurrahman Şahin; Hakan Artaş; Gökhan Artaş
Journal:  Turk J Gastroenterol       Date:  2020-10       Impact factor: 1.852

2.  Sarcoidosis with Rare Extrapulmonary Involvement.

Authors:  Marta Brandão Calçada; Sara Montezinho; Andreia M Teixeira; Bruno Gomes; Bernardo Macedo
Journal:  Eur J Case Rep Intern Med       Date:  2021-07-12

3.  Usefulness and problems of cytological examination by endobronchial ultrasound-guided transbronchial needle aspiration in the diagnosis of mediastinal lymphadenopathy: A retrospective single-centre study.

Authors:  Kaori Sandoh; Mitsuaki Ishida; Kimiaki Okano; Hiroko Ito; Koji Tsuta
Journal:  Mol Clin Oncol       Date:  2021-05-19

4.  Concurrent primary Sjögren's syndrome and isolated ocular sarcoidosis presenting with bilateral corneal scarring and dry eye.

Authors:  David Cui; Tiffany S Liu; Priya M Mathews; Alan N Baer; Esen K Akpek
Journal:  Am J Ophthalmol Case Rep       Date:  2020-06-17

5.  A case of bone marrow involvement in sarcoidosis with crescentic glomerular lesions.

Authors:  Mayu Sugai; Okinori Murata; Hiroki Oikawa; Hiroshi Katagiri; Ami Matsumoto; Hiromi Nagashima; Tamotsu Sugai; Makoto Maemondo
Journal:  Respir Med Case Rep       Date:  2020-08-28

6.  A Rare Case of Systemic Sarcoidosis in a Middle-Aged Female with a Solitary Thyroid Nodule.

Authors:  Ayrton Bangolo; John Bukasa Kakamba; Ali Atoot; Mohammad Jurri; Ashraf Mahmoud; Arthur Oliver Lo; Kunchang Song; Syed Sirajuddin; Adam Atoot
Journal:  Case Rep Endocrinol       Date:  2021-12-21

Review 7.  Environmental Risk Factors for Sarcoidosis.

Authors:  Marc A Judson
Journal:  Front Immunol       Date:  2020-06-26       Impact factor: 7.561

Review 8.  Developing better drugs for pulmonary sarcoidosis: determining indications for treatment and endpoints to assess therapy based on patient and clinician concerns.

Authors:  Marc A Judson
Journal:  F1000Res       Date:  2019-12-30

Review 9.  How to Tackle the Diagnosis and Treatment in the Diverse Scenarios of Extrapulmonary Sarcoidosis.

Authors:  Dominique Valeyre; Florence Jeny; Cécile Rotenberg; Diane Bouvry; Yurdagül Uzunhan; Pascal Sève; Hilario Nunes; Jean-François Bernaudin
Journal:  Adv Ther       Date:  2021-07-22       Impact factor: 3.845

10.  Associations between occupational and environmental exposures and organ involvement in sarcoidosis: a retrospective case-case analysis.

Authors:  Steven Ronsmans; Jolien De Ridder; Eline Vandebroek; Stephan Keirsbilck; Benoit Nemery; Peter H M Hoet; Steven Vanderschueren; Wim A Wuyts; Jonas Yserbyt
Journal:  Respir Res       Date:  2021-08-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.